Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Sam Boal/Rollingnews.ie

Reader Q&A: What do you want to know about the Covid-19 vaccines and their roll-out in Ireland?

With three vaccines now approved for use in the EU – and each reporting supply issues – what do you want to know?

THERE ARE NOW three Covid-19 vaccines approved for use across the European Union.

The most recently approved vaccine, produced by AstraZeneca, has been the source of some controversy after the company told the European Commission its deliveries of vaccines in the first quarter of this year will be reduced.

The European Medicines Agency has recommended its use for all adults aged over 18, which means it can potentially be administered to all adults as part of Ireland’s vaccine programme.

However, there is still uncertainty about the level of protection it provides for those over the age of 65 and the German authorities have said they will not administer the jab to the country’s older population due to a lack of data.

All three developers with vaccines approved by the EMA (Pfizer/BioNTech, Moderna and AstraZeneca) have told EU countries that their vaccine deliveries will be reduced, impacting on roll-out schedules, including in Ireland. 

With three vaccines approved, we’re continuing our Covid-19 Q&A series to help answer questions you may have, either about a specific vaccine or about how Ireland’s vaccine programme is working.

Send us your questions to answers@thejournal.ie and we’ll do our best to get through as many as we can, with a piece this weekend covering the main topics raised by readers. 

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
JournalTv
News in 60 seconds